News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SR Pharma PLC (SPA.L) To Conduct Full Toxicological Evaluation Of RNAi Candidate Atu027



1/31/2007 4:22:12 PM

LONDON (AFX) - Biopharmaceutical company SR Pharma PLC said it will proceed with a full, 28-day toxicological evaluation of its RNAi product candidate Atu027 before starting clinical testing later this year.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES